Introduction
Abnormally low excretion of 3', 5' cyclic adenosine monophosphate (cAMP) has been reported in patients with depressive illness (Abdulla and Hamadah, 1970; Paul et al., 1970) . Abdulla and Hamadah suggested that depressive illness is due to a severe fall in the intracellular level of cAMP in all tissues, including those of the central nervous system. Several factors have been found to influence cAMP levels in body fluids and tissues. An increase in the urinary level has been noted after the administration of tricycic antidepressants, and these have been shown to be inhibitors of cAMP phosphodiesterase (Abdulla and Hamadah, 1970; Ramsden, 1970) . Recent studies by Kodama et al. (1971) on brain slices suggest that imipramine, desipramine, and amitriptyline stimulate the formation of cAMP. Electrical stimulation has also been found. to increase the level of cAMP in cerebral cortical slices (Kakiuchi et al., 1969; Shimizu et al., 1970) , and this response was synergistic with that of histamine or noradrenaline but was prevented by previous treatment with a methyLxanthine such as theophylline (Kakiuchi et al., 1969; Sattin and Rall, 1970) .
Electric convulsion therapy (E.C.T.) has long been accepted as an effective form of treatment in some types of depression, and we therefore decided to examine the effect of E.C.T. on the urinary excretion of cAMP. Patients and Methods The investigation was carried out on 14 women inpatients at Tooting Bec Hospital suffering from depressive symptoms who were judged clinically to require treatment with E.C.T. The only additional criteria for selection were the willingness and the ability of the patients to co-operate in the investigation. Patients with heart or kidney diseases were excluded. The age range was from 24 to 61 years. Throughout the period of the study the patients were given a diet that lacked foods which might affect indole and catecholamine excretion . No alcohol was permitted and tea and coffee intake was stabilized. Patients were clinically assessed on the day before E.C.T., on the day of treatment, and on the following day to detect any sudden or pronounced change in mood. All participants received antidepressants or tranquillizers, or both, the doses of which were fixed throughout the period of the study. E.C.T. was administered regularly between 09.30 and 11.00 hours on Tuesdays and Fridays. All patients received 0-6 mg of atropine sulphate as premedication half to one hour before treatment. In 11 patients, who received a total of 19 treatments, the convulsion was modified by the intravenous injection of 60-70 mg of methohexitone sodium and 25-50 mg of suxamethonium chloride immediately before E.C.T. In the last two patients in the E.C.T. group, who received a total of seven treatments, the convulsion was modified by the intravenous injection of 250 mg of thiopentone sodium and 30-50 mg of suxamethonium bromide. The E.C.T. was administered with an Ectonus mark 3 A.C. mains model (Ectron Ltd.). The electrodes (Ectonus head-band) were lightly soaked in Ectronolyte solution and applied bitemporofrontally. The rotary control was used to apply the potential in a series of increasing steps, reaching a maximum of 140 V; the current was passed for about one second. The patients were well oxygenated with 100% oxygen.
On three occasions patients received all the preliminary treatment but for various reasons, including instrument failure, no shock was delivered. As they had experienced the anticipatory anxiety and had received atropine sulphate, methohexitone sodium, suxamethonium chloride, but not the electric shock they were regarded as controls on these occasions. A fourth patient, who received the atropine sulphate but panicked before further treatment could be given and refused it, was regarded as a separate control. Thus the controls (see Table) were achieved by chance rather than design. It was felt to be unacceptable on ethical grounds to enlarge this control group.
Twenty-four-hour specimens of urine (07.00-07.00 hours) were collected for up to three days before the first E.C.T. to establish a baseline for each individual patient and to determine the day-to-day variation of cAMP excretion. Twenty-four-hour soecimens were also collected on the day of E.C.T., for two days after E.C.T., and, where appropriate, on the days between subsequent treatments. The total urinary output over each 
Mean values with S.E. of mean and number of samples in parentheses.
Patient received 0-6 mg atropine sulphate only. Comparison of the paired data for cAMP excretion before E.C.T. with excretion on the day of E.C.T. gives P <0 001. For Cases 9-13 a double-blind procedure was usd Only after assaying all specimens was the code disclosed.
25.
24-hour period was pooled over 1 ml of chloroform, thoroughly mixed, and a 10-ml sample stored at -20°C until analysis. The completeness of the collection was checked by determination of the creatinine content as described by Varley (1969) . cAMP was determined by the enzymic-radioisotopic displacement method essentially as described by Brooker et al. (1968) .
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The changes in cAMP excretion resulting from the administration of E.C.T. in a typical case are shown in the Chart. Twelve of the 13 patients who received E.C.T. (see Table) showed a significant rise in urinary cAMP excretion on the day of treatment, when the mean value for the 13 patients (26 treatments) was 14-2 tamol/24 hr compared with a mean of 4-2 Vmol/24 hr for the period before E.C.T. (P <0001). In general the excretion of cAMP fell on the following day but not necessarily to the pre-E.C.T. level. The four controls showed a fall in the urinary excretion of cAMP on the day of (abortive) treatment (see Table) . Discussion A rise in urinary cAMP excretion after E.C.T. could be due to one or more of the following factors: anticipatory anxiety, premedication, anaesthesia, the administration of muscle relaxant, hypoxia, or electrical stimulation. The failure of the four controls to show any increase in cAMP excretion suggests that E.C.T. was the major factor responsible for the rise in cAMP excretion observed in this investigation. This conclusion is supported by the results of other studies. The work of Cox and Potkonjuk (1969) , and of Robison et al. (1971) suggests that atropine would have little or no effect at the dose level used. Wilson (1969) showed that barbiturates lower cAMP levels in Daily urinary cAMP excretion in a patient who received E.C.T. on days 4 and 8.
the rat brain, and Havens et al. (1959) showed that thiopentone and suxamethonium reduce the postconvulsive levels of catecholamines in the plasma of patients undergoing E.C.T. and hence probably also lower cAMP levels (Robison et al., 1971 ). The procedure used in E.C.T. needs to be carefully controlled to prevent hypoxia, which can result in various biochemical changes. Thus Havens et al. (1959) showed that the postconvulsive plasma level of adrenaline bears an inverse relation to the degree of oxygenation of the patient, while anoxia leads to a definite increase in the level of cAMP in mouse and rat brain (Goldberg et al., 1970; Ditzion et al., 1970) . In the present study the patients were well oxygenated, and the lack of increase in cAMP level in the three suxamethonium-treated controls again points to convulsive electric shock as the causative factor.
The mechanism by which electrical stimulation increases the 440 BRITISH lalff jouRNAL 19 AuGusT 1972 level of cAMP in the brain remains to be established. Although the direct administration of the monoamines noradrenaline and histamine into rat cerebral cortex causes prolonged activation of adenyl cyclase (Chou et al., 1971 ) the E.C.T.-induced increase in brain cAMP content cannot be completely explained by the action of these amines, since electrical stimulation of guinea-pig cerebral cortex produces an accumulation of cAMP over and above that produced by either noradrenaline or histamine . Currently the most plausible suggestion is that depolarization results in increased release of adenine-ribose compounds, which then stimulate cAMP formation . This study has shown that E.C.T. produced an increase in the urinary excretion of cAMP, which may be due to increased tissue levels of cAMP or to an increased rate of elimination. The direct electrical stimulation of slices of guinea-pig cerebral cortex, however, rapidly produces a greatly increased level of cortical cAMP (Kakiuchi et al., 1969; Shimizu et al., 1970) , and, furthermore, evidence has been obtained to support the suggestion that cAMP mediates the physiological actions of neural transmitter substances in the central nervous system (Florendo et al., 1971; Greengard and Kuo, 1970) . Possibly, therefore, the antidepressant action of E.C.T. is mediated through an increased production of cAMP in the brain, which is reflected in the increase observed in the urine of E.C.T.-treated patients.
